Perioperative use of levosimendan: best practice in operative settings.

Abstract

LEVOSIMENDAN HAS BEEN USED in clinical practice since 2000, especially in the care of heart-failure patients. It probably is the most studied inotropic agent ever, with 83 randomized controlled trials published about adult critically ill patients1 (PubMed search updated January 6, 2012). The moecular mechanisms of levosimendan action recently have been… (More)
DOI: 10.1053/j.jvca.2012.04.007

3 Figures and Tables

Topics

  • Presentations referencing similar topics